Welcome to our dedicated page for PKS news (Ticker: PKS), a resource for investors and traders seeking the latest updates and insights on PKS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PKS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PKS's position in the market.
POSCO HOLDINGS (NYSE: PKX) has announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024. The filing was completed on April 29, 2025, with the U.S. Securities and Exchange Commission.
Investors and interested parties can access the 2024 Annual Report through multiple channels:
- Download from POSCO's official website: www.posco-inc.com
- Access via the SEC website: www.sec.gov
- Request a free hard copy directly from the company
This regulatory filing represents POSCO's compliance with SEC requirements for foreign companies listed on U.S. exchanges, ensuring transparency and disclosure of their financial performance and operations for the 2024 fiscal year.
